Healthcare M&A may be entering a more active period, but the obstacles to getting deals done are becoming increasingly fragmented.
Hospital leaders broadly agree that performance improvement remains unfinished business. What they do not agree on is where the biggest gap actually sits.
Hospital investors are entering the second half of 2026 with a relatively clear priority: prove that operating performance can translate into earnings.
AI-powered diagnostics, remote monitoring, automation platforms, and virtual care solutions have attracted billions in investment and generated thousands of startups.
Every cycle in digital health produces a new infrastructure layer.
Healthcare services M&A has entered a more selective phase.
Healthcare M&A Is Poised for a Recovery in 2026. The Industry Still Sees Three Structural Barriers Standing in the Way.
Margin protection in healthcare used to mean one thing: cut costs faster than revenue slows.
Healthcare leaders consistently cite regulation as both a safeguard and a source of operational drag.
